<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24146116</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1179-1934</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>28</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>CNS drugs</Title>
                <ISOAbbreviation>CNS Drugs</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.</ArticleTitle>
            <Pagination>
                <MedlinePgn>79-88</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40263-013-0120-8</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The US Food and Drug Administration's meta-analyses of placebo-controlled antidepressant trials found approximately twice the rate of suicidal behaviors among children and adults aged 24 years and younger who were randomized to receive antidepressant medication than among those who were randomized to placebo. Rates of suicidal behavior were similar for subjects aged 25-64 years whether they received antidepressants or placebo, and subjects aged 65 years or older randomized to antidepressants were found to have lower rates of suicidal behavior. The age-stratified FDA meta-analyses did not have adequate power to investigate rates of suicidal behaviors by antidepressant drug class.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our objective was to assess the risk of deliberate self-harm associated with the two most commonly prescribed classes of antidepressant agents.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Propensity score matched cohort study of incident users of antidepressant agents.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">Population-based healthcare utilization data of US residents.</AbstractText>
                <AbstractText Label="PATIENTS" NlmCategory="METHODS">US residents aged 10-64 years with a recorded diagnosis of depression who initiated use of selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) between 1 January 1998 and 31 December 2010.</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">ICD-9 external cause of injury codes E950.x-E958.x (deliberate self-harm).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 102,647 patients aged between 10 and 24 years, and 338,021 aged between 25 and 64 years, initiated therapy with antidepressants. Among 10-24 year olds, prior to propensity score matching, 75,675 initiated therapy with SSRIs and 5,344 initiated SNRIs. After matching, there were 5,344 SNRI users and 10,688 SSRI users. Among the older cohort, 36,037 SNRI users were matched to 72,028 SSRI users (from an unmatched cohort of 225,952 SSRI initiators). Regardless of age cohort, patients initiating SSRIs and patients initiating SNRIs had similar rates of deliberate self-harm. Restriction to patients with no antidepressant use in the past 3 years did not alter our findings.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings of similar rates of deliberate self-harm for depressed patients who initiate treatment with either an SSRI or an SNRI suggests that physicians who have decided that their patients would benefit from initiating antidepressant therapy need not weigh differential suicide risk when deciding which class of antidepressant to prescribe.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Policy and Management, Harvard School of Public Health, 677 Huntigton Ave, Boston, MA, 02115, USA, mmiller@hsph.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pate</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swanson</LastName>
                    <ForeName>S A</ForeName>
                    <Initials>SA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Azrael</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>White</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>St√ºrmer</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AG023178</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 MH085021</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01MH085021</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>CNS Drugs</MedlineTA>
            <NlmUniqueID>9431220</NlmUniqueID>
            <ISSNLinking>1172-7047</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018759">Adrenergic Uptake Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018759" MajorTopicYN="N">Adrenergic Uptake Inhibitors</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016728" MajorTopicYN="N">Self-Injurious Behavior</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017367" MajorTopicYN="N">Serotonin Uptake Inhibitors</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24146116</ArticleId>
            <ArticleId IdType="doi">10.1007/s40263-013-0120-8</ArticleId>
            <ArticleId IdType="pmc">PMC3947090</ArticleId>
            <ArticleId IdType="mid">NIHMS533676</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Assoc Thai. 1998 Jul;81(7):551-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9676095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1995 Nov 15;142(10):1103-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7485055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2004 Jul 21;292(3):338-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15265848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2010 May;125(5):876-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20385637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Psychiatry. 1992 Nov;53(11):401-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1364815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):25-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16553526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Feb 28;373(9665):746-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19185342</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychiatry Neurosci. 2003 Sep;28(5):331-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14517576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1978 Sep 28;299(13):690-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">355881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Drugs. 2004;18(15):1119-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15581382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2007 Feb 3;334(7587):242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17164297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2007;(3):CD004851</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17636776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Depress Anxiety. 2009;26(8):752-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19544314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2010;340:c249</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20139216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Geriatr Psychiatry. 2001 Feb;16(2):231-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11241732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Psychopharmacol. 2012 Jun;32(3):346-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22544011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Compr Psychiatry. 1996 Mar-Apr;37(2):122-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8654061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2005 Feb 19;330(7488):389</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15718538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 2010 May;67(5):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20439831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Psychiatry. 2007 Sep;52(9):553-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17953159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Psychiatry. 1989 Sep;50(9):339-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2549018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 2008 Aug 1;168(3):329-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18515793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Saf. 1993 Mar;8(3):186-212</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8452661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009;339:b2880</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19671933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Psychiatry. 2005 Sep;162(9):1756-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16135644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Psychiatry. 2006 May;163(5):813-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16648321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1990 Nov 7;264(17):2219-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2214099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 2006 Mar;63(3):332-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16520440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychiatr Res. 2009 Feb;43(5):526-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18778837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Psychiatry. 2006 Nov;189:393-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17077427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Rev. 1990;12:87-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2286228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Psychiatry. 1992 Dec;161:735-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1306668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Affect Disord. 2009 Apr;114(1-3):143-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18692250</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
